skip to content
Aging and heart failure : mechanisms and management Preview this item
ClosePreview this item
Checking...

Aging and heart failure : mechanisms and management

Author: Bodh I Jugdutt
Publisher: New York : Springer, [2014] ©2014
Edition/Format:   eBook : Document : EnglishView all editions and formats
Database:WorldCat
Summary:
This book synthesizes the major research advances in molecular, biochemical, and translational aspects of aging and heart failure over the last four decades and addresses future directions in management and drug discovery. It presents clinical issues and molecular mechanisms related to heart failure, including the changing demographics in the aging population with heart failure; hypertension and prevention of  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

 

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Electronic books
Additional Physical Format: Print version:
Jugdutt, Bodh I.
Aging and heart failure : mechanisms and management.
New York, New York ; Heidelberg, [Germany] : Springer Science+Business Media, ©2014
xxii, 475 pages
(LCCN) 2014931487
Material Type: Document, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Bodh I Jugdutt
ISBN: 9781493902682 1493902687 1493902679 9781493902675
OCLC Number: 871204822
Description: 1 online resource : illustrations
Contents: Changing Demographics of the Aging Population with Heart Failure and Implications for Therapy --
Biology of Aging and Implications for Heart Failure Therapy and Prevention --
Hypertension and Prevention of Diastolic Heart Failure in the Aging Population --
Aging and Optimal Therapy of Systolic Heart Failure in the Elderly --
Atrial Fibrillation and Heart Failure in the Aging Population --
Optimizing Therapy of Heart Failure in the Aging Population with Monitoring in Clinics --
Cardiac Alterations in Aging, Hypertension, and Diastolic Heart Failure --
Polypharmacy and Adverse Drug Reactions in the Aging Population with Heart Failure --
Age-Related Changes in Vascular Biology and Implications for Heart Failure Therapy in the Aging Population --
Biomarkers and Optimal Management of Heart Failure in the Aging Population --
Benefits of Exercise in the Elderly --
The RAAS in Heart Failure: An Update on Clinical Trials and Opportunities for Therapy --
Aging and Diastolic Dysfunction: The Interplay of Inflammation and Extracellular Matrix Regulation --
Reperfusion and Vasodilator Therapy in Elderly Patients with STEMI and Heart Failure: Improving Outcomes --
Erythropoietin Therapy for Heart Failure --
Role of Resistin in Heart Failure in the Elderly --
Role of Coronary Artery Calcium in Cardiovascular Risk Stratification and Management in the Aging Population --
Aging and Remodeling of the RAS and RAAS and Related Pathways: Implications for Heart Failure Therapy --
Aging and Right Ventricular Failure from Pulmonary Hypertension: Effect of Right Ventricular and Pulmonary Artery Remodeling --
Aging and Right Ventricular Failure from Pulmonary Hypertension: Effect of Right Ventricular and Pulmonary Artery Remodeling --
Biomarkers of Cardiovascular Aging --
Changes in the Heart That Accompany Advancing Age: Humans to Molecules --
Aging-Related Changes in Cell Death and Cell Survival Pathways and Implications for Heart Failure Therapy --
Aging-Related Changes in Telomeres and Telomerases and Implications for Heart Failure Therapy --
Aging-Associated Alterations in Myocardial Inflammation and Fibrosis: Pathophysiological Perspectives and Clinical Implications --
Aging-Related Changes in Extracellular Matrix: Implications for Ventricular Remodeling Following Myocardial Infarction --
Calcium-Handling Defects and Changes in Cardiac Function in the Aging Heart --
Integrins: Implications for Aging in Heart Failure Therapy --
Adipokines as Novel Biomarkers in Aging and Heart Failure --
Aging-Related Changes in Cellular and Molecular Mechanisms of Postinfarction Remodeling: Implications for Heart Failure Therapy --
Aging-Related Changes in Mitochondrial Function and Implication for Heart Failure Therapy --
Regulation of SERCA Via Oxidative Modifications: Implications for the Pathophysiology of Diastolic Dysfunction in the Aging Heart --
SMP30 and Aging-Related Cardiac Remodeling and Heart Failure.
Responsibility: Bodh I. Jugdutt, editor.

Abstract:

Aging and Heart Failure  Read more...

Reviews

Editorial reviews

Publisher Synopsis

From the reviews: "This book details the clinical, physiological, and molecular aspects of heart failure pathophysiology, diagnosis, and management. ... The book caters mainly to advanced care Read more...

 
User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


<http://www.worldcat.org/oclc/871204822>
library:oclcnum"871204822"
library:placeOfPublication
rdf:typeschema:MediaObject
rdf:typeschema:Book
rdf:valueUnknown value: dct
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:bookFormatschema:EBook
schema:contributor
schema:datePublished"2014"
schema:description"Changing Demographics of the Aging Population with Heart Failure and Implications for Therapy -- Biology of Aging and Implications for Heart Failure Therapy and Prevention -- Hypertension and Prevention of Diastolic Heart Failure in the Aging Population -- Aging and Optimal Therapy of Systolic Heart Failure in the Elderly -- Atrial Fibrillation and Heart Failure in the Aging Population -- Optimizing Therapy of Heart Failure in the Aging Population with Monitoring in Clinics -- Cardiac Alterations in Aging, Hypertension, and Diastolic Heart Failure -- Polypharmacy and Adverse Drug Reactions in the Aging Population with Heart Failure -- Age-Related Changes in Vascular Biology and Implications for Heart Failure Therapy in the Aging Population -- Biomarkers and Optimal Management of Heart Failure in the Aging Population -- Benefits of Exercise in the Elderly -- The RAAS in Heart Failure: An Update on Clinical Trials and Opportunities for Therapy -- Aging and Diastolic Dysfunction: The Interplay of Inflammation and Extracellular Matrix Regulation -- Reperfusion and Vasodilator Therapy in Elderly Patients with STEMI and Heart Failure: Improving Outcomes -- Erythropoietin Therapy for Heart Failure -- Role of Resistin in Heart Failure in the Elderly -- Role of Coronary Artery Calcium in Cardiovascular Risk Stratification and Management in the Aging Population -- Aging and Remodeling of the RAS and RAAS and Related Pathways: Implications for Heart Failure Therapy -- Aging and Right Ventricular Failure from Pulmonary Hypertension: Effect of Right Ventricular and Pulmonary Artery Remodeling -- Aging and Right Ventricular Failure from Pulmonary Hypertension: Effect of Right Ventricular and Pulmonary Artery Remodeling -- Biomarkers of Cardiovascular Aging -- Changes in the Heart That Accompany Advancing Age: Humans to Molecules -- Aging-Related Changes in Cell Death and Cell Survival Pathways and Implications for Heart Failure Therapy -- Aging-Related Changes in Telomeres and Telomerases and Implications for Heart Failure Therapy -- Aging-Associated Alterations in Myocardial Inflammation and Fibrosis: Pathophysiological Perspectives and Clinical Implications -- Aging-Related Changes in Extracellular Matrix: Implications for Ventricular Remodeling Following Myocardial Infarction -- Calcium-Handling Defects and Changes in Cardiac Function in the Aging Heart -- Integrins: Implications for Aging in Heart Failure Therapy -- Adipokines as Novel Biomarkers in Aging and Heart Failure -- Aging-Related Changes in Cellular and Molecular Mechanisms of Postinfarction Remodeling: Implications for Heart Failure Therapy -- Aging-Related Changes in Mitochondrial Function and Implication for Heart Failure Therapy -- Regulation of SERCA Via Oxidative Modifications: Implications for the Pathophysiology of Diastolic Dysfunction in the Aging Heart -- SMP30 and Aging-Related Cardiac Remodeling and Heart Failure."@en
schema:description"This book synthesizes the major research advances in molecular, biochemical, and translational aspects of aging and heart failure over the last four decades and addresses future directions in management and drug discovery. It presents clinical issues and molecular mechanisms related to heart failure, including the changing demographics in the aging population with heart failure; hypertension and prevention of diastolic heart failure in the aging population; polypharmacy and adverse drug reactions in the aging population with heart failure; changes in the heart that accompany advancing age from humans to molecules; aging-associated alterations in myocardial inflammation and fibrosis; and aging-related changes in mitochondrial function and implications for heart failure therapy. The book succinctly summarizes the large volume of data on these key topics and highlights novel pathways that need to be explored. Featuring contributions from leading clinician-scientists, Aging and Heart Failure: Mechanisms and Management is an authoritative resource on the major clinical issues in heart failure therapy in the elderly for cardiologists, gerontologists, and internists."@en
schema:exampleOfWork<http://worldcat.org/entity/work/id/1821733840>
schema:genre"Electronic books"@en
schema:inLanguage"en"
schema:name"Aging and heart failure : mechanisms and management"@en
schema:url<http://site.ebrary.com/id/10839118>
schema:url<http://dx.doi.org/10.1007/978-1-4939-0268-2>
schema:url<http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=706140>
schema:workExample
schema:workExample
wdrs:describedby

Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.